Last updated 2026-07-20
- Acquired Nebion, Aug 2021
- Acquired Dropprint Genomics, Mar 2021
Total raised
—
Last: Undisclosed Round 2021-10
Stage
Series B
Founded
2018
Headcount
180
HQ
New York City, United States
Sector
Health Tech & Life Sciences
About
Immunai is an AI-driven biotechnology company that uses single-cell genomics and machine learning to comprehensively map and decode the human immune system. Their proprietary AMICA-OS platform integrates large-scale immune data with AI models to generate insights that can be used in drug development, biomarker identification, and clinical trial decision-making for immunology and oncology therapies. The company aims to accelerate the development of novel therapies by deeply understanding immune cell behavior and providing a comprehensive, end-to-end solution from data generation and curation to therapeutics development.
Acquisitions · 2
Aug 2021
Nebion
Undisclosed
Mar 2021
Dropprint Genomics
Undisclosed
Headcount over time
180 employees (2026-09) · 1 point
Offices
New York City, United States · HQ / main office
Show all offices (1 more)
- New York, United States
Q&A
- What is Immunai's primary focus?
- Immunai is developing a proprietary data set of multi-omic, immune-centric peripheral tissue analyses. Its platform is currently used to develop and refine cell therapies for neuroblastoma in conjunction with the Baylor College of Medicine.
- When was Immunai founded?
- Immunai was founded in January 2019.
- What was Immunai's most recent funding round?
- In October 2021, Immunai raised $215 million in a funding round led by Koch Disruptive Technologies.
- What was Immunai's second funding round?
- In February 2021, Immunai raised $60 million in a funding round.
- What was Immunai's first recorded funding round?
- In May 2020, Immunai raised $20 million in a funding round led by TLV Partners.
- What is the total amount of funding Immunai has raised to date?
- Immunai has raised a total of $295 million in funding.
- Which companies has Immunai acquired?
- Immunai acquired Dropprint Genomics in March 2021 and Nebion in August 2021.
- What is Immunai's primary sector?
- Immunai's primary sector is Health Tech & Life Sciences.
- Who are the co-founders of Immunai?
- The co-founders of Immunai are Noam Solomon (Co-founder & CEO), Luis Voloch (Co-founder & CTO), and Ansuman Satpathy (Scientific Co-Founder).
Team · 16
Noam Solomon
Founder · CEO & Co-Founder
Luis Voloch
Founder · Co-Founder
Ansuman Satpathy
Founder · Scientific Co-Founder
Danny Wells
Founder · Scientific Co-Founder
Dan Littman
Founder · Scientific Co-Founder
Daniel Cohen
COO
Yaniv Hamou
CFO
Tali Raveh-Sadka
VP, R&D
Adeeb Rahman
CTO
Evan Zisholtz
VP, Global BD
Elisha Nathan
VP, Strategic Alliances
Galit Yahalom
VP, Data
Ronit Weinstein
VP, Human Resources
Robert S. Langer
Board member
Mikael Dolsten
Board member
Stanley Frankel
Board member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Business SoftwareIT, R&D & Data SolutionsData Analysis & Decision SupportHealth Tech & Life SciencesDigital HealthcareMedical Decision SupportPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceDeep LearningMachine Learning
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersLife SciencesPharmaceuticals
Business model
B2B
Tags
clinical-trialsimmunotherapyunicorn-2021digital-healthcarehospitalsimmunologydata-analyticsactionable-insightspharma-companiescancerautoimmune-diseasesartificial-intelligencemachine-learningdeep-learningcells
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | immunai.com |
|---|---|
| linkedin.com/company/53085519 | |
| YouTube | youtube.com/channel/UChTYZlcgoung0EZlsgq-G6g |
| Wikidata | wikidata.org/wiki/Q107519302 |
Identifiers & details
| Founded | 2018-12 |
|---|---|
| Employees (exact) | 180 |
| Offices | New York |
| Wikidata QID | Q107519302 |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| Nebion | 2021-08 | |
| Dropprint Genomics | 2021-03 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | immunai.com |
|---|
Wikidata
| QID | Q107519302 |
|---|
Certificate / subdomain footprint
| Subdomains | 12 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515981934 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-02-17 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 3 — violation (1), people (2) |
| Registered address | דרך אבא הלל 21 רמת גן |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |
| 2026-02-11 | עדכון דירקטורים-הסרת דירקטור |
| 2026-05-05 | עדכון בעלי תפקידים |